Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Bryostatin-1

EU orphan designation number: EU/3/02/099
Active ingredient: Bryostatin-1
Indication: Treatment of oesophageal cancer
Sponsor: GPC Biotech AG
Fraunhoferstraße 20, D-82152 Martinsried/Munich, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/05/2002 Centralised Orphan - Designation EMEA/OD/002/02 (2002)1831 of 30/04/2002
06/11/2006 Centralised Orphan - Removal of orphan designation from Community Register